Gabriel Yariv
Chairman at CNBX PHARMACEUTICALS INC.
Profile
Gabriel Yariv was the founder of Instituto Simutec, founded in 2010, where he held the title of Chief Executive Officer from 2010 to 2017.
He was also the founder of The Yariv Foundation For Leadership Ltd., founded in 2006, where he held the title of Chief Executive Officer from 2006 to 2009.
Mr. Yariv's current job(s) include being the Chairman & Chief Operating Officer at CNBX Pharmaceuticals, Inc. since 2019, a Director at TaGeza Biopharmaceuticals Ltd., and a Member at Friends of The Israel Museum Society.
Mr. Yariv's education history includes undergraduate studies at Boston University.
Gabriel Yariv active positions
| Companies | Position | Start |
|---|---|---|
| CNBX PHARMACEUTICALS INC. | Chairman | 2021-09-04 |
| Friends of The Israel Museum Society | Corporate Officer/Principal | - |
TaGeza Biopharmaceuticals Ltd.
 TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TaGeza Biopharmaceuticals Ltd. develops immunotherapy and cancer-targeted pharmaceuticals. The private company is based in Tel Aviv Jaffa, Israel. | Director/Board Member | - |
Former positions of Gabriel Yariv
| Companies | Position | End |
|---|---|---|
| Instituto Simutec | Founder | 2016-12-31 |
| The Yariv Foundation For Leadership Ltd. | Chief Executive Officer | 2008-12-31 |
Training of Gabriel Yariv
| Boston University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CNBX PHARMACEUTICALS INC. | Health Technology |
| Private companies | 4 |
|---|---|
| Instituto Simutec | |
| Friends of The Israel Museum Society | |
| The Yariv Foundation For Leadership Ltd. | |
TaGeza Biopharmaceuticals Ltd.
TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TaGeza Biopharmaceuticals Ltd. develops immunotherapy and cancer-targeted pharmaceuticals. The private company is based in Tel Aviv Jaffa, Israel. | Health Technology |
- Stock Market
- Insiders
- Gabriel Yariv
